Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S9SQ
|
||||
Former ID |
DIB016754
|
||||
Drug Name |
JCAR015
|
||||
Indication | B-cell lymphoma [ICD9: 202.8; ICD10:C85.1] | Phase 2 | [525305] | ||
Company |
Juno therapeutics
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD19 | Target Info | Modulator | [551860] | |
NetPath Pathway | IL-7 Signaling Pathway | ||||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.